NASDAQ:HSDT Solana (HSDT) Stock Price, News & Analysis $2.29 -0.07 (-2.97%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$2.28 -0.01 (-0.44%) As of 05/22/2026 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solana Stock (NASDAQ:HSDT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Solana alerts:Sign Up Key Stats Today's Range$2.28▼$2.4150-Day Range$1.70▼$2.3952-Week Range$1.59▼$217.63Volume107,037 shsAverage Volume225,629 shsMarket Capitalization$133.71 millionP/E RatioN/ADividend YieldN/APrice Target$3.50Consensus RatingModerate Buy Company Overview Helius Medical Technologies, Inc. (NASDAQ: HSDT) is a medical technology company focused on developing and commercializing non‐invasive neuromodulation platforms designed to enhance neurorehabilitation. Its flagship product, the Portable Neuromodulation Stimulator (PoNS®), delivers mild electrical pulses to the tongue to stimulate neural pathways in conjunction with targeted physical therapy. The device is intended to improve neuroplasticity and support recovery in patients with neurological conditions. The PoNS system is cleared for use in the United States, Canada and the European Union and is prescribed through specialized rehabilitation clinics. Frameworks of care vary by region but typically involve coordinated therapy protocols that combine the wearable stimulator, physical exercises and clinician-led monitoring. Helius supports its clinical users with training, device management and remote patient engagement tools to optimize rehabilitation outcomes. Beyond its core PoNS offering, Helius is advancing an at-home digital therapy program that integrates software-guided exercises and telehealth support. The company collaborates with research institutions and rehabilitation centers to broaden the evidence base for its technology and explore applications in conditions such as mild traumatic brain injury, multiple sclerosis and stroke recovery. Ongoing clinical studies aim to expand indications and refine therapy protocols. Founded in 2015 and headquartered in Toronto, Ontario, Helius Medical Technologies is led by President and Chief Executive Officer Dan M. Toutant. Since its inception, the company has pursued regulatory clearances across key markets and built partnerships with rehabilitation specialists to bring neuromodulation therapies to patients worldwide.AI Generated. May Contain Errors. Read More Solana Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreHSDT MarketRank™: Solana scored higher than 71% of companies evaluated by MarketBeat, and ranked 229th out of 866 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingSolana has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialSolana has a consensus price target of $3.50, representing about 52.8% upside from its current price of $2.29.Amount of Analyst CoverageSolana has only been the subject of 4 research reports in the past 90 days.Read more about Solana's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Solana are expected to grow in the coming year, from ($0.09) to ($0.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solana is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Solana is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSolana has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.53% of the float of Solana has been sold short.Short Interest Ratio / Days to CoverSolana has a short interest ratio ("days to cover") of 5.52.Change versus previous monthShort interest in Solana has recently decreased by 9.89%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolana does not currently pay a dividend.Dividend GrowthSolana does not have a long track record of dividend growth. News and Social Media1.7 / 5News Sentiment-0.34 News SentimentSolana has a news sentiment score of -0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Solana this week, compared to 2 articles on an average week.Search Interest1 people have searched for HSDT on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Solana to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solana insiders have not sold or bought any company stock.Percentage Held by Insiders14.40% of the stock of Solana is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions18.63% of the stock of Solana is held by institutions.Read more about Solana's insider trading history. Receive HSDT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solana and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HSDT Stock News HeadlinesSolana (HSDT) Q1 2026 Earnings TranscriptMay 19, 2026 | finance.yahoo.comSolana Company targets Pacific Backbone nodes operational in late June after $8M raise at $2.60 per shareMay 16, 2026 | msn.comNobody Understands Why Trump Is Invading Iran (here’s the answer)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.May 23 at 1:00 AM | Banyan Hill Publishing (Ad)Solana Company (HSDT) Q1 2026 Earnings Call TranscriptMay 15, 2026 | seekingalpha.comSolana Company Reports First Quarter 2026 Financial ResultsMay 15, 2026 | globenewswire.comSolana Company to Release First Quarter 2026 Operating Results on May 15, 2026May 11, 2026 | globenewswire.comJito Foundation and Solana Company Announce Strategic Partnership to Enhance Institutional Adoption of Solana in APAC RegionMay 6, 2026 | quiverquant.comQJito Foundation and Solana Company (NASDAQ: HSDT) Announce Strategic Partnership to Expand Institutional Solana Infrastructure Across Asia-Pacific RegionMay 6, 2026 | globenewswire.comSee More Headlines HSDT Stock Analysis - Frequently Asked Questions How have HSDT shares performed this year? Solana's stock was trading at $2.89 at the beginning of 2026. Since then, HSDT shares have decreased by 20.8% and is now trading at $2.29. How were Solana's earnings last quarter? Solana Company (NASDAQ:HSDT) posted its quarterly earnings data on Friday, May, 15th. The company reported ($1.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by $0.96. The firm earned $3.62 million during the quarter, compared to analyst estimates of $3.40 million. Solana had a negative net margin of 1,427.15% and a negative trailing twelve-month return on equity of 67.57%. Read the conference call transcript. When did Solana's stock split? Solana's stock reverse split on the morning of Tuesday, July 1st 2025.The 1-50 reverse split was announced on Friday, June 27th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 30th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. Who are Solana's major shareholders? Top institutional shareholders of Solana include Kathmere Capital Management LLC (8.37%), Yorkville Advisors Global LP (1.98%), Polar Asset Management Partners Inc. (0.23%) and Saba Capital Management L.P. (0.12%). View institutional ownership trends. How do I buy shares of Solana? Shares of HSDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solana investors own include HubSpot (HUBS), Netflix (NFLX), Riot Platforms (RIOT), Tesla (TSLA), Company Calendar Last Earnings5/15/2026Today5/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (5m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 HSDT's financial health is in the Red zone, according to TradeSmith. HSDT has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:HSDT CIK1610853 Webheliusmedical.com Phone(877) 564-0008FaxN/AEmployees30Year Founded2018Price Target and Rating Average Price Target for Solana$3.50 High Price Target$4.00 Low Price Target$3.00 Potential Upside/Downside+52.8%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($109.67) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$40.89 million Net Margins-1,427.15% Pretax Margin-1,427.17% Return on Equity-67.57% Return on Assets-24.09% Debt Debt-to-Equity RatioN/A Current Ratio9.90 Quick Ratio9.96 Sales & Book Value Annual Sales$6.02 million Price / Sales22.21 Cash FlowN/A Price / Cash FlowN/A Book Value$3.39 per share Price / Book0.68Miscellaneous Outstanding Shares58,390,000Free Float49,979,000Market Cap$133.71 million OptionableNot Optionable Beta1.06 Social Links 7 Stocks to Ride The A.I. MegaboomWe are about to experience the greatest A.I. boom in stock market history... Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s. That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom. Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day. And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly... Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy. Get This Free Report This page (NASDAQ:HSDT) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solana Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Solana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
